CHEN BING CHUEN ALBERT (陳炳泉) V. CHINA STEM CELLS HOLDINGS LIMITED (and 7 others)

[2026] HKCFA 8 Court of Final Appeal 12 February 2026 • FAMV138/2025; FAMV139/2025; FAMV140/2025; FAMV141/2025; FAMV143/2025; FAMV144/2025; FAMV145/2025; FAMV146/2025 • 26 min read
3 cases cited (0 SG, 3 foreign)

Judges (3)

Fok Coram Lam Coram Ribeiro Coram

Counsel (9)

Jones Day Firm Lee & Yik Lawyers Firm Tanner De Witt Firm Anson Wong Counsel Applicant John Chan Counsel Respondent Martin Kok Counsel Applicant Rimsky Yuen Counsel Respondent Sabrina Leung Counsel Applicant William Wong Counsel Applicant

Parties (8)

China Stem Cells (East) Company Limited Defendant China Stem Cells Holdings Limited Plaintiff China in Shine Investment Limited Defendant Prime Intelligent Management Limited Defendant Chen Bing Chuen Albert Defendant Notake Minori Defendant Sonoe Muramatsu Defendant Zheng Ting Defendant

Summary

Chen Bing Chuen Albert and other defendants in consolidated proceedings brought by China Stem Cells Holdings Limited sought leave to appeal to the Court of Final Appeal regarding claims of fraudulent breach of fiduciary duty and proprietary remedies over BVI company shares. The Appeal Committee refused leave on most questions but granted leave on a narrow question concerning the proper approach to proprietary remedies for breach of fiduciary duty.

Cases Cited (3)

UK (1)
[2020] EWHC 194
HK (2)
[2024] HKCFI 481 [2025] HKCA 326

Judgment

Read the full judgment on the official Hong Kong Courts portal.

Read on HKLII

Source: HKLII ([2026] HKCFA 8)